Coordination Chemistry of the Antitumor Metallocene Molybdocene Dichloride with Biological Ligands

Inorganic Chemistry

Volumn 43, Issue 1, 2004, Pages 206-213

  Waern, Jenny B ^a   Harding, Margaret M ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ANTINEOPLASTIC AGENT; CARBOXYLIC ACID; COORDINATION COMPOUND; CYSTEINE; DNA; GLUTATHIONE; HETEROCYCLIC COMPOUND; HISTIDINE; LIGAND; LYSINE; MOLYBDOCENE DICHLORIDE; NUCLEOTIDE; PHOSPHATE; RIBOSE PHOSPHATE; THIOL; UNCLASSIFIED DRUG; WATER;

ANTINEOPLASTIC ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG EFFECT; DRUG MECHANISM; IN VIVO STUDY; PH; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PROTON NUCLEAR MAGNETIC RESONANCE; SOLUBILITY;

AMINO ACIDS; ANTINEOPLASTIC AGENTS; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; ORGANOMETALLIC COMPOUNDS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 0348223852     PISSN: 00201669     EISSN: None     Source Type: Journal    
DOI: 10.1021/ic034892q     Document Type: Article

References (57)

1. Köpf-Maier, P.; Köpf, H. Angew. Chem., Int. Ed. Engl. 1979, 18, 477-478.
2. Köpf-Maier, P.; Köpf, H. Z. Naturforsch. 1979, 34b, 805-807.
3. Köpf-Maier, P.; Köpf, H. Naturwissenschaften 1980, 67, 415-416.
4. Köpf-Maier, P.; Köpf, H. Struct. Bonding 1988, 70, 103-185.
5. Berdel, W. E.; Schmoll, H. J.; Scheulen, M. E.; Korfel, A.; Knoche, M. F.; Harstrci, A.; Bach, F.; Baumgart, J.; Sass, G. J. Cancer Res. Clin. Oncol. 1994, 120[Suppl], R172.
6. Christodoulou, C. V.; Ferry, D. R.; Fyfe, D. W.; Young, A.; Doran, J.; Sheehan, T. M. T.; Eliopoulos, A.; Hale, K.; Baumgart, J.; Sass, G.; Kerr, D. J. J. Clin. Oncol. 1998, 16, 2761-2769.
7. Korfel, A.; Scheulen, M. E.; Schmoll, H. J.; Gründel, O.; Harstrick, A.; Knoche, M.; Fels, L. M.; Skorzec, M.; Bach, F.; Baumgart, J.; Sass, G.; Seeber, S.; Thiel, E.; Berdel, W. E. Clin. Cancer Res. 1998, 4, 2701-2708.
8. Kröger, N.; Kleeberg, U. R.; Mross, K.; Edler, L.; Sass, G.; Hossfeld, D. K. Onkologie 2000, 23, 60-62.
9. Lümmen, G.; Sperling, S.; Luboldt, H.; Otto, T.; Rübben, H. Cancer Chemother. Pharmacol. 1998, 42, 415-417.
10. Köpf-Maier, P.; Köpf, H.; Wagner, W. Naturwissenschaften 1981, 68, 272-273.
11. Köpf-Maier, P.; Krahl, D. Naturwisenschaften 1981, 68, 273-274.
12. Köpf-Maier, P.; Krahl, D. Chem. Biol. Interact. 1983, 44, 317-328.
13. Harding, M. M.; Mokdsi, G. Curr. Med. Chem. 2000, 7, 1289-1303.
14. Köpf-Maier, P. J. Struct. Biol. 1990, 105, 35-45.
15. McLaughlin, M. L.; Cronan, J. M., Jr.; Schaller, T. R.; Snelling, R. D. J. Am. Chem. Soc. 1990, 112, 8949-8952.
16. Toney, J. H.; Marks, T. J. J. Am. Chem. Soc. 1985, 107, 947-953.
17. Murray, J. H.; Harding, M. M. J. Med. Chem. 1994, 37, 1936-1941.
18. Toney, J. H.; Brock, C. P.; Marks, T. J. J. Am. Chem. Soc. 1986, 108, 7263-7274.
19. Harding, M. M.; Prodigalidad, M.; Lynch, M. J. J. Med. Chem. 1996, 39, 5012-5016.
20. Kuo, L. Y.; Kanatzidis, M. G.; Sabat, M.; Tipton, A. L.; Marks, T. J. J. Am. Chem. Soc. 1991, 113, 9027-9045.
21. Kuo, L. Y.; Kanatzides, M. G.; Marks, T. J. J. Am. Chem. Soc. 1987, 109, 7207-7209.
22. Kuo, L. Y.; Liu, A. H.; Marks, T. J. In Metal Ions in Biological Systems; Sigel, A., Sigel, H., Eds.; Marcel Dekker: New York, 1996; Vol. 33, pp 53-85.
23. Harding, M. M.; Harden, G. J.; Field, L. D. FEBS Lett. 1993, 322, 291-294.
24. Harding, M. M.; Mokdsi, G.; Mackay, J. P.; Prodigalidad, M.; Lucas, S. W. Inorg. Chem. 1998, 37, 2432-2437.
25. Mokdsi, G.; Harding, M. M. J. Inorg. Biochem. 2001, 83, 205-209.
26. Mokdsi, G.; Harding, M. M. J. Inorg. Biochem. 2001, 86, 611-616.
27. Glasoe, P. K.; Long, F. A. J. Phys. Chem. 1960, 64, 188-190.
28. Balzarek, C.; Weakley, T. J. R.; Kuo, L. Y.; Tyler, D. R. Organometallics 2000, 19, 2927-2931.
29. Gore, E. S.; Green, M. L. H. J. Chem. Soc. A 1970, 2315-2319.
30. Prout, C. K.; Allison, G. B.; Delbaere, L. T. G.; Gore, E. Acta Crystallogr. 1972, B28, 3043-3056.
31. The compound number 3 is used in the text to indicate either 3a or zwitterionic 3b depending on solution pH. Similarly complex 6 contains six ionizable functional groups, and while the major species present at pH 7 is shown in Figure 4, other species may be present depending on the solution pH.
32. Klapötke, T. M.; Köpf, H.; Tornieporth-Oetting, I. C.; White, P. S. Organometallics 1994, 13, 3628-3633.
33. Klapötke, T. M.; Köpf, H.; Tornieporth-Oetting, I. C.; White, P. S. Angew. Chem., Int. Ed. Engl. 1994, 33, 1518-1519.
34. Köpf-Maier, P.; Köpf, H. Drugs Future 1986, 11, 297-320.
35. Köpf-Maier, P.; Köpf, H. In Metal Compounds in Cancer Therapy; Fricker, S. P., Ed.; Chapman and Hall: London, 1994; pp 109-146.
36. Köpf-Maier, P. In Metal Complexes In Cancer Chemotherapy; Keppler, B. K., Ed.; VCH Verlagsgesellschaft: Weinheim, 1993; pp 259-296.
37. Köpf-Maier, P.; Leitner, M.; Voigtländer, R.; Köpf, H. Z. Naturforsch. 1979, 34c, 1174-1176.
38. Prout, K.; Cameron, T. S.; Forder, R. A.; Critchley, S. R.; Denton, B.; Rees, G. V. Acta Crystallogr. 1974, B30, 2290-2304.
39. Prout, K.; Critchley, S. R.; Cannillo, E.; Tazzoli, V. Acta Crystallogr. 1977, B33, 456-462.
40. Mokdsi, G.; Harding, M. M. J. Organomet. Chem. 1998, 565, 29-35.
41. Köpf-Maier, P.; Tornieporth-Oetting, I. C. BioMetals 1996, 9, 267-271.
42. Klapötke, T. M.; Köpf, H.; Tornieporth-Oetting, I. C.; White, P. S. Angew. Chem., Int. Ed. Engl. 1994, 33, 1518-1519.
43. Tornieporth-Oetting, I. C.; White, P. S. Organometallics 1995, 14, 1632-1636.
44. Smets, M.-N.; Perbal, N.; Fastrez, J. Bull. Soc. Chim. Belg. 1985, 94, 1105-1106.
45. Green, M. L. H.; Lindsell, W. E. J. Chem. Soc. A 1967, 1455-1458.
46. Harriss, M. G.; Green, M. L. H.; Lindsell, W. E. J. Chem. Soc. A 1969, 1453-1455.
47. Gore, E.; Green, M. L. H.; Harriss, M. G.; Lindsell, W. E.; Shaw, H. J. Chem. Soc. A 1969, 1981-1983.
48. Calhorda, M. J.; Dias, A. R.; Martinho Simoes, J. A.; Teixeira, C. J. Chem. Soc., Dalton Trans. 1984, 2659-2663.
49. Carter, D. C.; Ho, J. X. Adv. Protein Chem. 1994, 45, 153-203.
50. Kratz, F. In Metal Complexes in Cancer Chemotherapy; Keppler, B. K., Ed. ; VCH Verlagsgesellschaft: Weinheim, 1993; pp 391-429.
51. Reedijk, J. Chem. Rev. 1999, 99, 2499-2510.
52. Reedjik, J. Proc. Natl. Acad. Sci. 2003, 100, 3611-3616.
53. Kratochwil, N. A.; Ivanov, A. I.; Patriarca, M.; Parkinson, J. A.; Gouldsworthy, A. M.; Murdoch, P. D. S.; Sadler, P. J. J. Am. Chem. Soc. 1999, 121, 8193-8203.
54. Dolman, R. C.; Deacon, G. B.; Hambley, T. W. J. Inorg. Biochem. 2002, 88, 260-267.
55. Trynda-Lemiesz, L.; Karaczyn, A.; Keppler, B. K.; Kozlowski, H. J. Inorg. Biochem. 2000, 78, 341-346.
56. Krezel, A.; Bal, W. Acta Biochim. Pol. 1999, 46, 567-580.
57. Jansen, B. A. J.; Brouwer, J.; Reedijk, J. J. Inorg. Biochem. 2002, 89, 197-202.